Heart and heart-lung transplantation in adults with congenital heart disease

Cindy M. Martin; James H. Moller

doi:10.1007/978-3-319-44577-9_33

Heart and heart-lung transplantation in adults with congenital heart disease

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Because of cardiac operations in children, more than a million adults with treated congenital heart disease survive. Those with complex anomalies, which may have been palliated, develop cardiac failure which may become resistant to medical treatment. For these patients heart or heart-lung transplantation offers an approach. In this chapter the indications and the UNOS classification for considering patients for transplantation are presented. Two factors may limit classification: inability to determine pulmonary vascular resistance in those with more than one source of pulmonary blood flow and secondly elevated HLA antibody levels from previous cardiac operations. There are unique factors that patients experience postoperatively, but 10-year survival is favorable.

Original language	English (US)
Title of host publication	Congestive Heart Failure and Cardiac Transplantation
Subtitle of host publication	Clinical, Pathology, Imaging and Molecular Profiles
Publisher	Springer International Publishing
Pages	539-547
Number of pages	9
ISBN (Electronic)	9783319445779
ISBN (Print)	9783319445755
DOIs	https://doi.org/10.1007/978-3-319-44577-9_33
State	Published - Jun 1 2017

Keywords

Adults
CHD
Congenital heart disease
Heart transplantation
Heart-lung transplantation

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1007/978-3-319-44577-9_33

OpenUrl availability

Full text

Cite this

@inbook{e0b0df409a47472797d970798e98c687,

title = "Heart and heart-lung transplantation in adults with congenital heart disease",

abstract = "Because of cardiac operations in children, more than a million adults with treated congenital heart disease survive. Those with complex anomalies, which may have been palliated, develop cardiac failure which may become resistant to medical treatment. For these patients heart or heart-lung transplantation offers an approach. In this chapter the indications and the UNOS classification for considering patients for transplantation are presented. Two factors may limit classification: inability to determine pulmonary vascular resistance in those with more than one source of pulmonary blood flow and secondly elevated HLA antibody levels from previous cardiac operations. There are unique factors that patients experience postoperatively, but 10-year survival is favorable.",

keywords = "Adults, CHD, Congenital heart disease, Heart transplantation, Heart-lung transplantation",

author = "Martin, {Cindy M.} and Moller, {James H.}",

year = "2017",

month = jun,

day = "1",

doi = "10.1007/978-3-319-44577-9_33",

language = "English (US)",

isbn = "9783319445755",

pages = "539--547",

booktitle = "Congestive Heart Failure and Cardiac Transplantation",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Heart and heart-lung transplantation in adults with congenital heart disease

AU - Martin, Cindy M.

AU - Moller, James H.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Because of cardiac operations in children, more than a million adults with treated congenital heart disease survive. Those with complex anomalies, which may have been palliated, develop cardiac failure which may become resistant to medical treatment. For these patients heart or heart-lung transplantation offers an approach. In this chapter the indications and the UNOS classification for considering patients for transplantation are presented. Two factors may limit classification: inability to determine pulmonary vascular resistance in those with more than one source of pulmonary blood flow and secondly elevated HLA antibody levels from previous cardiac operations. There are unique factors that patients experience postoperatively, but 10-year survival is favorable.

AB - Because of cardiac operations in children, more than a million adults with treated congenital heart disease survive. Those with complex anomalies, which may have been palliated, develop cardiac failure which may become resistant to medical treatment. For these patients heart or heart-lung transplantation offers an approach. In this chapter the indications and the UNOS classification for considering patients for transplantation are presented. Two factors may limit classification: inability to determine pulmonary vascular resistance in those with more than one source of pulmonary blood flow and secondly elevated HLA antibody levels from previous cardiac operations. There are unique factors that patients experience postoperatively, but 10-year survival is favorable.

KW - Adults

KW - CHD

KW - Congenital heart disease

KW - Heart transplantation

KW - Heart-lung transplantation

UR - http://www.scopus.com/inward/record.url?scp=85054688163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054688163&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-44577-9_33

DO - 10.1007/978-3-319-44577-9_33

M3 - Chapter

AN - SCOPUS:85054688163

SN - 9783319445755

SP - 539

EP - 547

BT - Congestive Heart Failure and Cardiac Transplantation

PB - Springer International Publishing

ER -

Heart and heart-lung transplantation in adults with congenital heart disease

Abstract

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this